TY - JOUR AU - Roll, P. AU - Palanichamy, A. AU - Kneitz, C. AU - Dorner, T. AU - Tony, H. -. P. PY - 2006 DA - 2006// TI - Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22019 DO - 10.1002/art.22019 ID - Roll2006 ER - TY - STD TI - Popa C, Leandro MJ, Cambridge G, Edwards JCW. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs Rheumatology. 2007;46(4):626–30. ID - ref2 ER - TY - JOUR AU - Vollenhoven, R. F. AU - Emery, P. AU - Bingham, C. O. AU - Keystone, E. C. AU - Fleischmann, R. AU - Furst, D. E. PY - 2010 DA - 2010// TI - Long-term safety of patients receiving rituximab in rheumatoid arthritis clinical trials JO - J Rheumatol VL - 37 UR - https://doi.org/10.3899/jrheum.090856 DO - 10.3899/jrheum.090856 ID - Vollenhoven2010 ER - TY - JOUR AU - Keogh, K. A. AU - Ytterberg, S. R. AU - Fervenza, F. C. AU - Carlson, K. A. AU - Schroeder, D. R. AU - Specks, U. PY - 2006 DA - 2006// TI - Rituximab for refractory Wegener's granulomatosis JO - Am J Respir Crit Care Med VL - 173 UR - https://doi.org/10.1164/rccm.200507-1144OC DO - 10.1164/rccm.200507-1144OC ID - Keogh2006 ER - TY - JOUR AU - Holle, J. U. AU - Dubrau, C. AU - Herlyn, K. AU - Heller, M. AU - Ambrosch, P. AU - Noelle, B. PY - 2012 DA - 2012// TI - Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/ard.2011.153601 DO - 10.1136/ard.2011.153601 ID - Holle2012 ER - TY - JOUR AU - Albert, D. AU - Dunham, J. AU - Khan, S. AU - Stansberry, J. AU - Kolasinski, S. AU - Tsai, D. PY - 2008 DA - 2008// TI - Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.083162 DO - 10.1136/ard.2007.083162 ID - Albert2008 ER - TY - JOUR AU - Pagnoux, C. AU - Guillevin, L. PY - 2015 DA - 2015// TI - French Vasculitis Study G, investigators M. Rituximab or azathioprine maintenance in ANCA-associated vasculitis JO - N Engl J Med VL - 372 ID - Pagnoux2015 ER - TY - JOUR AU - Venhoff, N. AU - Effelsberg, N. M. AU - Salzer, U. AU - Warnatz, K. AU - Peter, H. H. AU - Lebrecht, D. PY - 2012 DA - 2012// TI - Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0037626 DO - 10.1371/journal.pone.0037626 ID - Venhoff2012 ER - TY - STD TI - Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;23:2016;75(9):1583–94. ID - ref9 ER - TY - JOUR AU - Venhoff, N. AU - Niessen, L. AU - Kreuzaler, M. AU - Rolink, A. G. AU - Hässler, F. AU - Rizzi, M. PY - 2014 DA - 2014// TI - Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease JO - Autoimmunity VL - 47 UR - https://doi.org/10.3109/08916934.2014.914174 DO - 10.3109/08916934.2014.914174 ID - Venhoff2014 ER - TY - JOUR AU - Masi, A. T. AU - Hunder, G. G. AU - Lie, J. T. AU - Michel, B. A. AU - Bloch, D. A. AU - Arend, W. P. PY - 1990 DA - 1990// TI - The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) JO - Arthritis Rheum VL - 33 UR - https://doi.org/10.1002/art.1780330806 DO - 10.1002/art.1780330806 ID - Masi1990 ER - TY - STD TI - Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. 1990; 33(8):1101–7. ID - ref12 ER - TY - JOUR AU - Jones, R. B. AU - Ferraro, A. J. AU - Chaudhry, A. N. AU - Brogan, P. AU - Salama, A. D. AU - Smith, K. G. C. PY - 2009 DA - 2009// TI - A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24637 DO - 10.1002/art.24637 ID - Jones2009 ER - TY - JOUR AU - Smith, R. M. AU - Jones, R. B. AU - Jayne, D. R. PY - 2012 DA - 2012// TI - Progress in treatment of ANCA-associated vasculitis JO - Arthritis Res Ther VL - 14 UR - https://doi.org/10.1186/ar3797 DO - 10.1186/ar3797 ID - Smith2012 ER - TY - JOUR AU - Smith, R. M. AU - Jones, R. B. AU - Guerry, M. J. AU - Laurino, S. AU - Catapano, F. AU - Chaudhry, A. PY - 2012 DA - 2012// TI - Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34583 DO - 10.1002/art.34583 ID - Smith2012 ER - TY - JOUR AU - Smith, K. G. AU - Jones, R. B. AU - Burns, S. M. AU - Jayne, D. R. PY - 2006 DA - 2006// TI - Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22046 DO - 10.1002/art.22046 ID - Smith2006 ER - TY - JOUR AU - Tamura, N. AU - Matsudaira, R. AU - Hirashima, M. AU - Ikeda, M. AU - Tajima, M. AU - Nawata, M. PY - 2007 DA - 2007// TI - Two cases of refractory Wegener's granulomatosis successfully treated with rituximab JO - Intern Med VL - 46 UR - https://doi.org/10.2169/internalmedicine.46.6156 DO - 10.2169/internalmedicine.46.6156 ID - Tamura2007 ER - TY - JOUR AU - Breedveld, F. AU - Agarwal, S. AU - Yin, M. AU - Ren, S. AU - Li, N. F. AU - Shaw, T. M. PY - 2007 DA - 2007// TI - Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response JO - J Clin Pharmacol VL - 47 UR - https://doi.org/10.1177/0091270007305297 DO - 10.1177/0091270007305297 ID - Breedveld2007 ER - TY - JOUR AU - Vögelin, M. AU - Biedermann, L. AU - Frei, P. AU - Vavricka, S. R. AU - Scharl, S. AU - Zeitz, J. PY - 2016 DA - 2016// TI - The impact of azazioprine-associated lymphopenia on the onset of opportunistic infections in patients with inflammatory bowel disease JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0155218 DO - 10.1371/journal.pone.0155218 ID - Vögelin2016 ER - TY - JOUR AU - Al Rifai, A. AU - Prasad, N. AU - Shuttleworth, E. AU - McBurney, H. AU - Pushpakom, S. AU - Robinson, A. PY - 2011 DA - 2011// TI - Natural history of azathioprine-associated lymphopenia in inflammatory bowel disease patients: a prospective observational study JO - Eur J Gastroenterol Hepatol VL - 23 UR - https://doi.org/10.1097/MEG.0b013e32834233a2 DO - 10.1097/MEG.0b013e32834233a2 ID - Al Rifai2011 ER - TY - JOUR AU - Roberts, R. L. AU - Barclay, M. L. PY - 2015 DA - 2015// TI - Update on thiopurine pharmacogenetics in inflammatory bowel disease JO - Pharmacogenomics VL - 16 UR - https://doi.org/10.2217/pgs.15.29 DO - 10.2217/pgs.15.29 ID - Roberts2015 ER -